In contrast, our study revealed that anti-PAD4 antibodies are a rare finding in the serum and sputum of at-risk subjects and are only observed in the sputum of a subset of established RA patients with serum anti-PAD4 positivity. Here, PADI4 is linked to rheumatoid arthritis.